gr 127935 has been researched along with Chronic Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adnot, S; Eddahibi, S; Hamon, M; Marcos, E; Nosjean, A; Pham, MH; Raffestin, B | 1 |
Hicks, MN; Keegan, A; MacLean, MR; Morecroft, I; Smillie, D | 1 |
2 other study(ies) available for gr 127935 and Chronic Disease
Article | Year |
---|---|
Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension.
Topics: Analysis of Variance; Animals; Carrier Proteins; Chronic Disease; Citalopram; Disease Models, Animal; Fluoxetine; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Ketanserin; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Muscle, Smooth, Vascular; Nerve Tissue Proteins; Oxadiazoles; Piperazines; Pulmonary Artery; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Statistics, Nonparametric | 2003 |
Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935.
Topics: Animals; Atmosphere Exposure Chambers; Blood Pressure; Chronic Disease; Heart Rate; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Lung; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Organ Size; Oxadiazoles; Piperazines; Pulmonary Artery; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Vasoconstrictor Agents; Vasodilator Agents; Ventricular Dysfunction, Right | 2001 |